Tablets 20 mg

Solution for injection - (40 mg + 0.02 ml)/2 ml

Solution for injection - 5 mg/ml - 20 ml

Solution for injection - 10 mg/2 ml

Rectal solution - 5 mg/2.5 ml

Tablets - 100 mg

Sugar coated tablets - 25 mg

Solution for injection - (50%) 1 g/2 ml

Solution for injection - (5%) 100 mg/2 ml

Tablets - 75 mg

Tablets - 5 mg

Parkinsan contains the active substance trihexyphenidyl hydrochloride.

It is an antimuscarinic agent with similar effects as atropine.

It exerts direct inhibitory effect on the parasimpatique nervous system by inhibiting the effects of acetylcholine.

Parkinsan has also an antispasmodic effect on the smooth muscles.

Parkinsan 5 mg tablets are indicated:

• as supportive treatment for all forms of parkinsonism (postencephalytic, artheriosclerotic and idiopathic);
• as adjuvant therapy when treating the above-mentioned forms of parkinsonism with levodopa. It helps in reducing muscle rigidity and increased salivation that accompanies parkinsonism;
• as adjuvant therapy when using levodopa to control extrapyramidal disorders due to central nervous system drugs.

Tablets - 5 mg

Solution for injection - (0.5%) 10 mg/2 ml

Oral drops, solution - (0.2%) 2 mg/ml

Haloperidol belongs to a group of medicines called ‘antipsychotics’.

Haloperidol is used in adults, adolescents and children for illnesses affecting the way you think, feel or behave. These include mental health problems (such as schizophrenia and bipolar disorder) and behavioural problems.

These illnesses may make you:

• feel confused (delirium);
• see, hear, feel or smell things that are not there (hallucinations);
• believe things that are not true (delusions);
• feel unusually suspicious (paranoia);
• feel very excited, agitated, enthusiastic, impulsive or hyperactive;
• feel very aggressive, hostile or violent.

In adolescents and children, Haloperidol is used to treat schizophrenia in patients aged 13 to 17 years, and to treat behavioural problems in patients aged 6 to 17 years.

Haloperidol is also used:

• in adolescents and children aged 10 to 17 years and in adults for movements or sounds you can’t control (tics), for example in severe Tourette’s syndrome
• in adults to help control movements in Huntington’s disease.

Haloperidol is sometimes used when other medicines or treatments have not worked or caused unacceptable side effects.

Solution for injection - (0.5%) 5 mg/1 ml

Sugar coated tablets - 25 mg

Solution for injection - (96 mg + 104 mg)/1 ml (20%)

Caffeine is a substance that stimulates the CNS. It inhibits the enzyme phosphodiesterase and has an antagonistic effect at central adenosine receptors. In the CNS it acts primarily in the higher centers and gives a condition of wakefulness, increasing the rate and depth of respiration sometimes. Its stimulating action in vasomotor centers of medulla and the positive inotropic effect in the myocardium are compensated by the peripheral vasodilator effect in the arterioles, so it has little effect on blood pressure.

The diuretic action of caffeine is weaker than that of theophylline.

Caffeine can increase the absorption of ergotamine and sometimes is combined with the latter for the treatment of migraine. To increase the solubility of caffeine, it is combined with sodium benzoate and so is obtained caffeine sodium benzoate, which is used in the form of solution for injection.

Caffeine is well distributed in the body. It crosses the central nervous system and passes in saliva; in small concentrations it passes into breast milk.

This medicine is to be given only under the direct supervision of a doctor.

Kafeine natrium benzoat is indicated:

• as breathing and blood circulation analeptic, mainly in diseases with high temperature and infectious diseases, as well as during poisoning.

Film-coated tablets - 10 mg

Tablets - 200 mg

Solution for injection - (1%) 10 mg/ml